| Type | Description | Status | Start | End |
| signal peptide | | | 1 | 25 |
| chain | Fusion glycoprotein F0 | | 26 | 565 |
| chain | Fusion glycoprotein F2 | | 26 | 116 |
| chain | Fusion glycoprotein F1 | | 117 | 565 |
| disulfide bond | Interchain (between F2 and F1 chains) | | 70 | 199 |
| disulfide bond | | | 338 | 347 |
| disulfide bond | | | 362 | 370 |
| disulfide bond | | by similarity | 394 | 399 |
| disulfide bond | | by similarity | 401 | 424 |
| transmembrane region | | | 501 | 521 |
| topological domain | Extracellular | | 26 | 500 |
| topological domain | Cytoplasmic | | 522 | 565 |
| domain | Leucine-zipper | potential | 278 | 306 |
| region of interest | Fusion peptide | | 117 | 141 |
| glycosylation site | N-linked (GlcNAc...) | | 104 | 104 |
| glycosylation site | N-linked (GlcNAc...) | | 245 | 245 |
| glycosylation site | N-linked (GlcNAc...) | | 449 | 449 |
| sequence variant | | | 0 | 0 |
| sequence variant | (in strain: Mutant BY-4, Mutant BY-5, Mutant BY-13) | | 0 | 0 |
| sequence variant | (in strain: Mutant F1-R, Mutant F1-R / T-5 revertant, Mutant ts-f1) | | 0 | 0 |
| sequence variant | (in strain: wild-type, Mutant F1- R, Mutant F1-R / T-5 revertant, Mutant ts-f1) | | 0 | 0 |
| sequence variant | (in strain: Mutant BY-4, Mutant BY-13) | | 0 | 0 |
| sequence variant | (in strain: Mutant KD-22M) | | 0 | 0 |
| sequence variant | (in strain: Mutant KD-32, KD- 32M) | | 0 | 0 |
| sequence variant | (in strain: Mutant KD-32, KD- 32M) | | 0 | 0 |
| sequence variant | (in strain: Mutant KD-61) | | 0 | 0 |
| sequence variant | (in strain: Mutant KD-61) | | 0 | 0 |
| sequence variant | (in strain: Mutant F1-R, Mutant F1-R / T-5 revertant, Mutant ts-f1) | | 0 | 0 |
| sequence variant | (in strain: Mutant KD-51, Mutant KD-51M) | | 0 | 0 |
| sequence variant | (in strain: Mutant KD-22) | | 0 | 0 |
| sequence variant | (in strain: wild-type, Mutant F1- R, Mutant F1-R / T-5 revertant, Mutant ts-f1) | | 0 | 0 |
| sequence variant | (in strain: Mutant KD-51, Mutant KD-51M) | | 0 | 0 |
| sequence variant | (in strain: Mutant KD-52M) | | 0 | 0 |
| sequence variant | (in strain: Mutant KD-61) | | 0 | 0 |
| sequence variant | (in strain: Mutant KD-52M) | | 0 | 0 |
| sequence variant | (in strain: Mutant F1-R / T-5 revertant) | | 0 | 0 |
| sequence variant | (in strain: Mutant KD-21, Mutant KD-62) | | 0 | 0 |
| sequence variant | (in Mutant KD-21, Mutant KD- 52) | | 0 | 0 |
| sequence variant | (in strain: Mutant KD-41) | | 0 | 0 |
| sequence variant | (in strain: Mutant F1-R, Mutant F1-R / T-5 revertant, Mutant ts-f1) | | 0 | 0 |
| sequence variant | (in strain: Mutant KD-32) | | 0 | 0 |
| sequence variant | (in strain: Mutant KD-22M, Mutant KD-32M) | | 0 | 0 |
| sequence variant | (in strain: Mutant KD-62) | | 0 | 0 |
| sequence variant | (in strain: Mutant BF-41, Mutant BF-53, Mutant BF-82, Mutant BF-132) | | 0 | 0 |
| sequence variant | (in strain: Mutant KD-51, Mutant KD-51M) | | 0 | 0 |
| sequence variant | (in strain: Mutant KD-51M) | | 0 | 0 |
| sequence variant | (in strain: Mutant F1-R, Mutant F1-R / T-5 revertant, Mutant ts-f1) | | 0 | 0 |
| sequence variant | (in strain: Mutant KD-11, Mutant KD-11M) | | 0 | 0 |
| sequence variant | (in strain: Mutant KD-31, Mutant KD-61) | | 0 | 0 |
| sequence variant | (in strain: Mutant KD-52M) | | 0 | 0 |
| sequence variant | (in strain: Mutant F1-R, Mutant ts-f1) | | 0 | 0 |
| sequence variant | (in strain: Mutant KD-22 in Mutant KD-22M) | | 0 | 0 |
| site | Cleavage; by arginine-specific endoprotease | | 116 | 117 |
| mutagenesis site | Loss of glycosylation | | 0 | 0 |
| mutagenesis site | Inhibits transport of F and HN to the cell surface | | 0 | 0 |
| mutagenesis site | Inhibits transport of F and HN to the cell surface | | 0 | 0 |
| mutagenesis site | Inhibits transport of F and HN to the cell surface | | 0 | 0 |
| mutagenesis site | Inhibits transport of F and HN to the cell surface | | 0 | 0 |
| mutagenesis site | Inhibits transport of F and HN to the cell surface | | 0 | 0 |
| mutagenesis site | Inhibits transport of F and HN to the cell surface | | 0 | 0 |
| mutagenesis site | Inhibits transport of F and HN to the cell surface | | 0 | 0 |
| mutagenesis site | Inhibits transport of F and HN to the cell surface | | 0 | 0 |
| mutagenesis site | Loss of glycosylation, cell surface transport and F0 cleavage | | 0 | 0 |
| mutagenesis site | Inhibits transport of F and HN to the cell surface | | 0 | 0 |
| mutagenesis site | Loss of glycosylation, enhances cell fusion activity | | 0 | 0 |
| mutagenesis site | Inhibits transport of F and HN to the cell surface | | 0 | 0 |
| coiled-coil region | | potential | 142 | 170 |
| coiled-coil region | | potential | 466 | 491 |
